Valuation: Mega Lifesciences

Market Cap 30.08B 895M 787M 744M 675M 1.27B 85.9B 1.28B 8.91B 3.44B 43.83B 3.36B 3.29B 141B P/E 2026 *
12.7x
P/E 2027 * 12.1x
Enterprise Value 25.46B 758M 666M 630M 571M 1.07B 72.72B 1.08B 7.54B 2.91B 37.11B 2.84B 2.78B 119B EV / Sales 2026 *
1.77x
EV / Sales 2027 * 1.62x
Free-Float
38.66%
Yield 2026 *
5.1%
Yield 2027 * 5.5%
1 day-0.72%
1 week-3.50%
Current month-4.17%
1 month-4.83%
3 months-1.43%
6 months+0.73%
Current year+2.99%
1 week 34.25
Extreme 34.25
36.75
1 month 34.25
Extreme 34.25
36.75
Current year 31.5
Extreme 31.5
40
1 year 27.75
Extreme 27.75
40
3 years 24.3
Extreme 24.3
46.25
5 years 24.3
Extreme 24.3
56.5
10 years 17.9
Extreme 17.9
56.5
Manager TitleAgeSince
Chief Executive Officer 64 1987-12-31
Director of Finance/CFO 62 1996-12-31
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 62 1997-12-31
Director/Board Member 64 2012-12-31
Director/Board Member 73 2013-01-31
Date Insider Type Main position Quantity % Market Cap. Importance
4/29/25 Buy

Chief Executive Officer

100,000 0.0115%
4/28/25 Buy

Chief Executive Officer

50,000 0.0057%
4/28/25 Buy

Chief Executive Officer

150,000 0.0172%
Change 5-day change 1-year change 3-year change Capi.($)
-0.72%-3.50%+12.20%-21.59% 907M
+0.11%+1.71%+63.52%+117.61% 1,055B
+0.27%+0.92%+51.33%+73.35% 654B
+0.73%+0.68%+20.70%+74.90% 467B
-1.36%-2.58%+40.20%+42.33% 348B
+1.34%+4.53%+23.37%+29.55% 275B
-0.48%-0.54%+13.56%+13.50% 258B
+0.85%+6.35%+53.17%+54.39% 224B
+0.85%+1.10%+35.78%+101.82% 187B
-0.30%-2.98%-27.62%-61.28% 171B
Average +0.04%+0.05%+28.62%+42.46% 363.93B
Weighted average by Cap. -0.05%+1.00%+40.68%+69.82%

Financials

2026 *2027 *
Net sales 14.35B 427M 375M 355M 322M 605M 40.97B 608M 4.25B 1.64B 20.91B 1.6B 1.57B 67.18B 15.66B 466M 410M 388M 352M 660M 44.73B 664M 4.64B 1.79B 22.83B 1.75B 1.71B 73.35B
Net income 2.23B 66.37M 58.37M 55.19M 50.06M 94.02M 6.37B 94.57M 661M 255M 3.25B 249M 244M 10.45B 2.49B 73.94M 65.03M 61.49M 55.78M 105M 7.1B 105M 736M 284M 3.62B 278M 272M 11.64B
Net Debt -4.62B -137M -121M -114M -104M -195M -13.18B -196M -1.37B -528M -6.73B -516M -504M -21.62B -4.72B -140M -123M -117M -106M -199M -13.48B -200M -1.4B -540M -6.88B -527M -516M -22.1B
Logo Mega Lifesciences
Mega Lifesciences Public Company Limited is a Thailand-based company, which is engaged in health and wellness industry. Its segments include Brands, Distribution and OEM. MEGA We Care is its branded products business, through which it develops, manufactures, markets and sells its own range of nutraceuticals, complementary medicines, prescription pharmaceuticals and over the counter (OTC) health products. Maxxcare serves as its prominent distribution arm, specializing in the marketing, sales, and distribution of a range of branded prescription pharmaceuticals, OTC medications and fast-moving consumer goods (FMCG) across key markets such as Myanmar, Vietnam and Cambodia. Its suite of services encompasses warehouse management, collections and value-added initiatives, including tailored marketing services for principals in the pharmaceutical and FMCG sectors. Its manufacturing facilities in Thailand, Australia and Indonesia also accept production orders from various third-party customers.
Employees
-
Date Price Change Volume
26-09-28 THB 34.50 -0.72% 816,747
26-09-25 THB 34.75 +0.72% 438,571
26-09-24 THB 34.50 -4.17% 2,285,556
26-09-23 THB 36.00 0.00% 785,912
26-09-22 THB 36.00 +0.70% 883,660
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
34.50THB
Average target price
42.71THB
Spread / Average Target
+23.81%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEGA Stock